Clinical Trial Update: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II) [Phase 3]

View source ↗

Summary

Phase 3 trial of TTAX01, a cryopreserved human umbilical cord-derived product, for late-stage, complex non-healing diabetic foot ulcers has completed. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Infection
• Diabetic Foot Ulcer
• Wound

Drugs mentioned

• TTAX01

Snippet

Sponsor: BioTissue Holdings, Inc | Conditions: Diabetic Foot Infection, Non-healing Wound | Phase 3 | Status: COMPLETED